EARNINGS WATCH- Integrated Diagnostics Holdings (IDH) reported a 26% y-o-y increase in net profits to EGP 356 mn in 9M2018, according a regulatory filing (pdf). The consumer healthcare company’s 9M2018 revenues were up 25% y-o-y to EGP 1.38 bn. IDH’s focus on marketing efforts and test mix has “seen us extract higher value from increasing patient and test volumes,” which has allowed the company to deliver “outstanding profitability” despite of operating challenges, including double-digit inflation, devaluation in Sudan, and investment costs associated with growing and integrating its newly acquired Nigerian operation the company’s platform, said IDH CEO Hend El Sherbini.
More from Enterprise
Banque du Caire’s blockbuster IPO holds firm against EGX selloff
The IFC and the EBRD are in for USD 100…
Can AI promise Egypt’s lenders more borrowers and fewer bad loans?
Banks are cautious about letting AI judge a borrower. Local…
Egypt’s funds crossed EGP 500 bn in 3Q on retail money and a stalling core
Money market funds stalled while retail piled into equity, index,…
DPI closes Egypt-born fintech fund Nclude at USD 112 mn
The final close adds roughly USD 7 mn to a…